Nanocarriers, due to their unique features, are of increased interest among researchers
working with pharmaceutical formulations. Polymeric nanoparticles and nanocapsules …

The focus on nanotechnology in cancer treatment and diagnosis has intensified due to the
serious side effects caused by anticancer agents as a result of their cytotoxic actions on …

The purpose of the present study was to formulate effective and controlled release
albendazole liposomal formulations. Albendazole, a hydrophobic drug used for the …

Background: Although various injected peptide and protein therapeutics have been
developed successfully over the past 25 years, several pharmacokinetic and immunological …

Purpose To compare systemic intravenous and local intratracheal delivery of doxorubicin
(DOX), antisense oligonucleotides (ASO) and small interfering RNA (siRNA). Methods …

Anthracycline antibiotics are among the most effective and commonly used anticancer
drugs. Unfortunately, their clinical use is restricted by dose-dependent toxicity. Doxorubicin …

Promoting tumor angiogenesis effectively and specifically to resolve tumor‐associated
hypoperfusion holds promise for improving pancreatic cancer therapy. Herein, a doxorubicin …

Polylysine dendrimers have potential as biodegradable vectors for the delivery of cytotoxic
drugs to solid tumours. Here, the cytotoxicity, drug release and tumour targeting properties of …

Lipid-based drug-delivery systems have evolved from micro-to nano-scale, enhancing the
efficacy and therapeutic applications of these delivery systems. Production of lipid-based …

Desmoplastic tumors are normally resistant to nanoparticle-based chemotherapy due to
dense stroma and limited particle permeability inside the tumor. Herein, we reported that …